152 related articles for article (PubMed ID: 18369320)
1. Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy.
Hai M; Adler RL; Bauer TR; Tuschong LM; Gu YC; Wu X; Hickstein DD
Gene Ther; 2008 Jul; 15(14):1067-71. PubMed ID: 18369320
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
Bauer TR; Allen JM; Hai M; Tuschong LM; Khan IF; Olson EM; Adler RL; Burkholder TH; Gu YC; Russell DW; Hickstein DD
Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
[TBL] [Abstract][Full Text] [Related]
4. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy.
Bauer TR; Hai M; Tuschong LM; Burkholder TH; Gu YC; Sokolic RA; Ferguson C; Dunbar CE; Hickstein DD
Blood; 2006 Nov; 108(10):3313-20. PubMed ID: 16868255
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.
Hunter MJ; Zhao H; Tuschong LM; Bauer TR; Burkholder TH; Persons DA; Hickstein DD
Hum Gene Ther; 2011 Jun; 22(6):689-96. PubMed ID: 21275758
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
Hunter MJ; Tuschong LM; Fowler CJ; Bauer TR; Burkholder TH; Hickstein DD
Mol Ther; 2011 Jan; 19(1):113-21. PubMed ID: 20859258
[TBL] [Abstract][Full Text] [Related]
7. Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
Bauer TR; Olson EM; Huo Y; Tuschong LM; Allen JM; Li Y; Burkholder TH; Russell DW
Gene Ther; 2011 Jun; 18(6):553-9. PubMed ID: 21228879
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
Nelson EJ; Tuschong LM; Hunter MJ; Bauer TR; Burkholder TH; Hickstein DD
Gene Ther; 2010 May; 17(5):672-7. PubMed ID: 20164857
[TBL] [Abstract][Full Text] [Related]
9. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.
Schwarzwaelder K; Howe SJ; Schmidt M; Brugman MH; Deichmann A; Glimm H; Schmidt S; Prinz C; Wissler M; King DJ; Zhang F; Parsley KL; Gilmour KC; Sinclair J; Bayford J; Peraj R; Pike-Overzet K; Staal FJ; de Ridder D; Kinnon C; Abel U; Wagemaker G; Gaspar HB; Thrasher AJ; von Kalle C
J Clin Invest; 2007 Aug; 117(8):2241-9. PubMed ID: 17671654
[TBL] [Abstract][Full Text] [Related]
10. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.
Deichmann A; Hacein-Bey-Abina S; Schmidt M; Garrigue A; Brugman MH; Hu J; Glimm H; Gyapay G; Prum B; Fraser CC; Fischer N; Schwarzwaelder K; Siegler ML; de Ridder D; Pike-Overzet K; Howe SJ; Thrasher AJ; Wagemaker G; Abel U; Staal FJ; Delabesse E; Villeval JL; Aronow B; Hue C; Prinz C; Wissler M; Klanke C; Weissenbach J; Alexander I; Fischer A; von Kalle C; Cavazzana-Calvo M
J Clin Invest; 2007 Aug; 117(8):2225-32. PubMed ID: 17671652
[TBL] [Abstract][Full Text] [Related]
11. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
[TBL] [Abstract][Full Text] [Related]
12. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency.
Bauer TR; Creevy KE; Gu YC; Tuschong LM; Donahue RE; Metzger ME; Embree LJ; Burkholder T; Bacher JD; Romines C; Thomas ML; Colenda L; Hickstein DD
Blood; 2004 May; 103(9):3582-9. PubMed ID: 14715622
[TBL] [Abstract][Full Text] [Related]
13. Hot spots of retroviral integration in human CD34+ hematopoietic cells.
Cattoglio C; Facchini G; Sartori D; Antonelli A; Miccio A; Cassani B; Schmidt M; von Kalle C; Howe S; Thrasher AJ; Aiuti A; Ferrari G; Recchia A; Mavilio F
Blood; 2007 Sep; 110(6):1770-8. PubMed ID: 17507662
[TBL] [Abstract][Full Text] [Related]
14. Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency.
Creevy KE; Bauer TR; Tuschong LM; Embree LJ; Silverstone AM; Bacher JD; Romines C; Garnier J; Thomas ML; Colenda L; Hickstein DD
Vet Immunol Immunopathol; 2003 Oct; 95(3-4):113-21. PubMed ID: 12963272
[TBL] [Abstract][Full Text] [Related]
15. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
[TBL] [Abstract][Full Text] [Related]
16. Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency.
Gu YC; Bauer TR; Sokolic RA; Hai M; Tuschong LM; Burkholder T; Bacher J; Starost MF; Hickstein DD
Bone Marrow Transplant; 2006 Mar; 37(6):607-14. PubMed ID: 16444276
[TBL] [Abstract][Full Text] [Related]
17. Tracking of specific integrant clones in dogs treated with foamy virus vectors.
Ohmine K; Li Y; Bauer TR; Hickstein DD; Russell DW
Hum Gene Ther; 2011 Feb; 22(2):217-24. PubMed ID: 20738155
[TBL] [Abstract][Full Text] [Related]
18. Canine leukocyte adhesion deficiency colony for investigation of novel hematopoietic therapies.
Creevy KE; Bauer TR; Tuschong LM; Embree LJ; Colenda L; Cogan K; Starost MF; Haskins ME; Hickstein DD
Vet Immunol Immunopathol; 2003 Jul; 94(1-2):11-22. PubMed ID: 12842608
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.
Wang GP; Berry CC; Malani N; Leboulch P; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Bushman FD
Blood; 2010 Jun; 115(22):4356-66. PubMed ID: 20228274
[TBL] [Abstract][Full Text] [Related]
20. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
